Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine Armbruster

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Expert Opinion on Investigational Drugs|August 2, 2002
Novel treatments for recurrent respiratory papillomatosisChristine Armbruster
Acta Cytologica|May 27, 2008
Pulmonary tumorlet: a case report of a diagnostic pitfall in cytologyChristine Armbruster, Klaus Bernhardt, Ulrike Setinek
Wiener Klinische Wochenschrift|September 30, 2006
Neurosarcoidosis--a diagnostic pitfall with consequencesIrene Kapfhammer, Christine Armbruster, Christian Armbruster
Clinical Chemistry and Laboratory Medicine|April 6, 2004
Immunoglobulin G Fc(gamma) receptor expression on polymorphonuclear cells in bronchoalveolar lavage fluid of HIV-infected and HIV-seronegative patients with bacterial pneumoniaChristine Armbruster, Walter Krugluger, Monika Huber, et al.
Tissue Engineering|May 24, 2007
Current state of the art in myocardial tissue engineeringMarie-Noëlle Giraud, Christine Armbruster, Thierry Carrel, et al.
Onkologie|April 18, 2008
Ewing's sarcoma and peripheral primitive neuroectodermal tumor in adults: different features of a rare neoplasmChristine Armbruster, Monika Huber, Helmut Prosch, et al.
International Journal of Cardiology|March 31, 2009
Noncompaction in a HIV-positive with cortical blindness as initial manifestation of progressive multifocal leucencephalopathyJosef Finsterer, Claudia Stöllberger, Margarete Coulibaly-Wimmer, et al.
AIDS (London, England)|January 25, 2002
A phase I trial with two human monoclonal antibodies (hMAb 2F5, 2G12) against HIV-1Christine Armbruster, Gabriela M Stiegler, Brigitta A Vcelar, et al.
Antimicrobial Agents and Chemotherapy|April 28, 2006
Long-term multiple-dose pharmacokinetics of human monoclonal antibodies (MAbs) against human immunodeficiency virus type 1 envelope gp120 (MAb 2G12) and gp41 (MAbs 4E10 and 2F5)Beda Joos, Alexandra Trkola, Herbert Kuster, et al.
AIDS (London, England)|December 20, 2007
Reassessment of autoreactivity of the broadly neutralizing HIV antibodies 4E10 and 2F5 and retrospective analysis of clinical safety dataBrigitta Vcelar, Gabriela Stiegler, Hermann M Wolf, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Expert Opinion on Investigational Drugs|August 2, 2002
Novel treatments for recurrent respiratory papillomatosisChristine Armbruster
Acta Cytologica|May 27, 2008
Pulmonary tumorlet: a case report of a diagnostic pitfall in cytologyChristine Armbruster, Klaus Bernhardt, Ulrike Setinek
Wiener Klinische Wochenschrift|September 30, 2006
Neurosarcoidosis--a diagnostic pitfall with consequencesIrene Kapfhammer, Christine Armbruster, Christian Armbruster
Clinical Chemistry and Laboratory Medicine|April 6, 2004
Immunoglobulin G Fc(gamma) receptor expression on polymorphonuclear cells in bronchoalveolar lavage fluid of HIV-infected and HIV-seronegative patients with bacterial pneumoniaChristine Armbruster, Walter Krugluger, Monika Huber, et al.
Tissue Engineering|May 24, 2007
Current state of the art in myocardial tissue engineeringMarie-Noëlle Giraud, Christine Armbruster, Thierry Carrel, et al.
Onkologie|April 18, 2008
Ewing's sarcoma and peripheral primitive neuroectodermal tumor in adults: different features of a rare neoplasmChristine Armbruster, Monika Huber, Helmut Prosch, et al.
International Journal of Cardiology|March 31, 2009
Noncompaction in a HIV-positive with cortical blindness as initial manifestation of progressive multifocal leucencephalopathyJosef Finsterer, Claudia Stöllberger, Margarete Coulibaly-Wimmer, et al.
AIDS (London, England)|January 25, 2002
A phase I trial with two human monoclonal antibodies (hMAb 2F5, 2G12) against HIV-1Christine Armbruster, Gabriela M Stiegler, Brigitta A Vcelar, et al.
Antimicrobial Agents and Chemotherapy|April 28, 2006
Long-term multiple-dose pharmacokinetics of human monoclonal antibodies (MAbs) against human immunodeficiency virus type 1 envelope gp120 (MAb 2G12) and gp41 (MAbs 4E10 and 2F5)Beda Joos, Alexandra Trkola, Herbert Kuster, et al.
AIDS (London, England)|December 20, 2007
Reassessment of autoreactivity of the broadly neutralizing HIV antibodies 4E10 and 2F5 and retrospective analysis of clinical safety dataBrigitta Vcelar, Gabriela Stiegler, Hermann M Wolf, et al.
Pageof 2